2022-11-25 09:43:00

Venus Medtech to showcase its structural heart treatments at London Valves 2022

Logo PR Newswire
PR Newswire

The company's growing number of solutions for structural heart disease will be presented at multiple events during the conference between November 27-29

HANGZHOU, China, Nov. 25, 2022 /PRNewswire/ -- Venus Medtech is building an exciting pipeline of treatments for structural heart disease. The company will present its products at the conference taking place at the ExCeL London November 27-29, 2022 in its booth (#25), during a symposium, and at the official launch of the TARGET multicenter clinical study.

Structural heart symposium on November 27

The company will also be hosting a symposium on November 27 (Hall #4 at 17:30 pm) where top investigators will discuss the latest results and future plans for the Venus Medtech tricuspid and pulmonary valve replacement systems. During this symposium, "The Right Valves for The Right Ventricle: Venus MedTech tricuspid and pulmonary replacement systems," interventional cardiologists will have the opportunity to learn the latest about structural heart interventions.

Launch of TARGET CE Study for tricuspid valve replacement on November 28

Additionally, Venus Medtech will be officially launching the TARGET study at the conference. The TARGET study will evaluate the safety and performance of the Cardiovalve Tricuspid System—with its associated procedure—in reducing tricuspid regurgitation and the associated symptoms. The Cardiovalve system includes a valve and delivery system, designed for replacement of the tricuspid valve through a transcatheter approach. The study will enroll one hundred patients in up to thirty medical centers. Patients will be followed for a period of up to five years.

The TARGET CE Study will be launched officially at the Sunborn London Yacht Hotel on Monday, November 28 at 18:30 pm.

Presentation of new data

The experiences with Cardiovalve and presentation of new data will be held in the following sessions:

  • Dr. Estevez-Loureiro, Eliminate tricuspid regurgitation: transfemoral CardioValve tricuspid replacement system (Tricuspid interventions session, November 27, 13:30 - 15:00 at Interactive Case Corner 2).
  • Dr. Sherif, Transcatheter transseptal mitral valve implantation: a new tool-in-the-box for patients with severe mitral regurgitation (TMVR challenges session, November 27, 15:05 - 16:05, at Interactive Case Corner 2).
  • Dr. Schmidt, Transcatheter valve implantation in mitral and tricuspid valve position, (Rapid-fire clinical cases: Session 7, November 29, 14:50 - 15:35 at The Exchange).

About Venus Medtech: Increasing global presence

Venus Medtech (stock code: 2500.HK) is committed to structural heart innovation. As the leading transcatheter heart valve medical device player in China, Venus Medtech has established comprehensive solutions for structural heart disease. It now has a complete product pipeline covering all four heart valves, namely TAVR, TPVR, TMVR and TTVR, as well as hypertrophic cardiomyopathy, hypertensive renal denervation (RDN) therapy and relevant accessory products.

Venus is now intensifying its presence in overseas markets, making important breakthroughs in registration and commercialization.

For more information

Visit our conference website: www.venusmedtechconference.com

Cision View original content:https://www.prnewswire.com/news-releases/venus-medtech-to-showcase-its-structural-heart-treatments-at-london-valves-2022-301687134.html

SOURCE Venus Medtech (Hangzhou) Inc.

Logo EIN Presswire
HealthPress Release2022-11-24 13:30:00
Market Research Reports, Business Consulting Services & Analytics The use of holography to address the rising cases of heart surgeries has readily...

Logo PR Newswire
HealthPress Release2022-11-25 08:00:00
SUZHOU, China, Nov. 25, 2022 /PRNewswire/ -- inQB8 Medical Technologies, LLC (inQB8), in Partnership with Peijia Medical Limited (Peijia, (9996.HK)),...

Logo PR Newswire
HealthPress Release2022-11-24 10:45:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Technological Innovations and Growth Opportunities in Diagnostic Biochips" report has been added to...

Logo EIN Presswire
Medical Electronics Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 The Business Research Companys Medical Electronics Global...

Logo EIN Presswire
HealthPress Release2022-11-24 20:40:12
Gift of Life International Global Hearts Telethon, Thursday, November 29, 2022 Gift of Life International, Healing little hearts around the world

Logo PR Newswire
HealthPress Release2022-11-25 09:15:00
LAUSANNE, Switzerland, and PEYNIER, France, Nov. 25, 2022 /PRNewswire/ -- The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, the...

Logo PR Newswire
HealthPress Release2022-11-24 13:47:00
Medi S im VR was awarded the Start- u p of T he Y ear A ward by FICCI at their 14 th edition of the 'Healthcare Conference & Excellence Awards' held in...

Logo PR Newswire
HealthPress Release2022-11-24 14:15:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "3D Bioprinting Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...

Logo PR Newswire
HealthPress Release2022-11-24 16:45:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC),...

Logo PR Newswire
HealthPress Release2022-11-24 20:53:00
OTTAWA, ON, Nov. 24, 2022 /CNW/ - The Honourable Jean-Yves Duclos, Minister of Health and Government of Canada officials will provide an update on COVID-19...

Logo PR Newswire
TechnologyPress Release2022-11-24 10:00:00
ZURICH, Nov. 24, 2022 /PRNewswire/ -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that it has been...

Logo PR Newswire
HealthPress Release2022-11-24 20:00:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases (I to IV), Type (Small...

Logo PR Newswire
LONDON, Nov. 24, 2022 /PRNewswire/ -- Project MedTech has been named by Business Worldwide Magazine in its " Top 20 Most Innovate Companies to Watch, 2022"...

Logo EIN Presswire
HealthPress Release2022-11-24 10:34:33
Oncology Radiopharmaceuticals Market Radiation and radioactive compounds play a crucial role in therapeutic and diagnostic approaches in oncology....

Logo PR Newswire
HealthPress Release2022-11-24 17:00:00
Launch announced after CPP acquires 10th medical aesthetic clinic EDINA, Minn., Nov. 24, 2022 /PRNewswire/ -- Cosmetic Physician Partners Inc. (" CPP ") is...

Logo PR Newswire
HealthPress Release2022-11-24 18:45:00
DUBLIN, Nov. 24, 2022 /PRNewswire/ -- The "Liquid Biopsy Global Market Report 2022, By Product, By End User, By Clinical Application" report has been added...

Logo EIN Presswire
SciencePress Release2022-11-24 17:18:42
La HealthTech mexicana fue ganadora en la categora de Prevencin y Bienestar Empresarial, por un panel de lderes de Salud y de firmas de VC de Silicon Valley....

Logo PR Newswire
HealthPress Release2022-11-24 22:00:00
WINNIPEG, MB, Nov. 24, 2022 /CNW/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and...

Logo EIN Presswire
HealthPress Release2022-11-23 11:23:21
Cardiovascular Ultrasound Market A cardiovascular ultrasound is a type of ultrasound that focuses on heart and blood vessels. BURLINGAME, CA, UNITED STATES,...

Logo Benzinga
Business / FinanceBy Pr Newswire2022-11-24 17:00:00
Launch announced after CPP acquires 10th medical aesthetic clinic EDINA, Minn., Nov. 24, 2022 /PRNewswire/ -- Cosmetic Physician Partners Inc. ( CPP ) is...